BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 32358648)

  • 1. Assessing breast cancer risk within the general screening population: developing a breast cancer risk model to identify higher risk women at mammographic screening.
    Abdolell M; Payne JI; Caines J; Tsuruda K; Barnes PJ; Talbot PJ; Tong O; Brown P; Rivers-Bowerman M; Iles S
    Eur Radiol; 2020 Oct; 30(10):5417-5426. PubMed ID: 32358648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting interval and screen-detected breast cancers from mammographic density defined by different brightness thresholds.
    Nguyen TL; Aung YK; Li S; Trinh NH; Evans CF; Baglietto L; Krishnan K; Dite GS; Stone J; English DR; Song YM; Sung J; Jenkins MA; Southey MC; Giles GG; Hopper JL
    Breast Cancer Res; 2018 Dec; 20(1):152. PubMed ID: 30545395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derived mammographic masking measures based on simulated lesions predict the risk of interval cancer after controlling for known risk factors: a case-case analysis.
    Hinton B; Ma L; Mahmoudzadeh AP; Malkov S; Fan B; Greenwood H; Joe B; Lee V; Strand F; Kerlikowske K; Shepherd J
    Med Phys; 2019 Mar; 46(3):1309-1316. PubMed ID: 30697755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Women at High Risk of Breast Cancer Who Need Supplemental Screening.
    Eriksson M; Czene K; Strand F; Zackrisson S; Lindholm P; Lång K; Förnvik D; Sartor H; Mavaddat N; Easton D; Hall P
    Radiology; 2020 Nov; 297(2):327-333. PubMed ID: 32897160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of previous benign breast biopsy on the interpretive performance of subsequent screening mammography.
    Taplin SH; Abraham L; Geller BM; Yankaskas BC; Buist DS; Smith-Bindman R; Lehman C; Weaver D; Carney PA; Barlow WE
    J Natl Cancer Inst; 2010 Jul; 102(14):1040-51. PubMed ID: 20601590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localized mammographic density is associated with interval cancer and large breast cancer: a nested case-control study.
    Strand F; Azavedo E; Hellgren R; Humphreys K; Eriksson M; Shepherd J; Hall P; Czene K
    Breast Cancer Res; 2019 Jan; 21(1):8. PubMed ID: 30670066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel method of determining breast cancer risk using parenchymal textural analysis of mammography images on an Asian cohort.
    Tan M; Mariapun S; Yip CH; Ng KH; Teo SH
    Phys Med Biol; 2019 Jan; 64(3):035016. PubMed ID: 30577031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification of women with false-positive test results in mammography screening based on mammographic morphology and density: A case control study.
    Winkel RR; Euler-Chelpin MV; Lynge E; Diao P; Lillholm M; Kallenberg M; Forman JL; Nielsen MB; Uldall WY; Nielsen M; Vejborg I
    Cancer Epidemiol; 2017 Aug; 49():53-60. PubMed ID: 28558329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study.
    Strand F; Humphreys K; Cheddad A; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
    Breast Cancer Res; 2016 Oct; 18(1):100. PubMed ID: 27716311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers.
    Mandelson MT; Oestreicher N; Porter PL; White D; Finder CA; Taplin SH; White E
    J Natl Cancer Inst; 2000 Jul; 92(13):1081-7. PubMed ID: 10880551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The distribution and determinants of mammographic density measures in Western Australian aboriginal women.
    McLean K; Darcey E; Cadby G; Lund H; Pilkington L; Redfern A; Thompson S; Saunders C; Wylie E; Stone J
    Breast Cancer Res; 2019 Feb; 21(1):33. PubMed ID: 30819215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammographic density defined by higher than conventional brightness thresholds better predicts breast cancer risk.
    Nguyen TL; Aung YK; Evans CF; Dite GS; Stone J; MacInnis RJ; Dowty JG; Bickerstaffe A; Aujard K; Rommens JM; Song YM; Sung J; Jenkins MA; Southey MC; Giles GG; Apicella C; Hopper JL
    Int J Epidemiol; 2017 Apr; 46(2):652-661. PubMed ID: 28338721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.
    Vreemann S; van Zelst JCM; Schlooz-Vries M; Bult P; Hoogerbrugge N; Karssemeijer N; Gubern-Mérida A; Mann RM
    Breast Cancer Res; 2018 Aug; 20(1):84. PubMed ID: 30075794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combined effect of mammographic texture and density on breast cancer risk: a cohort study.
    Wanders JOP; van Gils CH; Karssemeijer N; Holland K; Kallenberg M; Peeters PHM; Nielsen M; Lillholm M
    Breast Cancer Res; 2018 May; 20(1):36. PubMed ID: 29720220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammographic density and structural features can individually and jointly contribute to breast cancer risk assessment in mammography screening: a case-control study.
    Winkel RR; von Euler-Chelpin M; Nielsen M; Petersen K; Lillholm M; Nielsen MB; Lynge E; Uldall WY; Vejborg I
    BMC Cancer; 2016 Jul; 16():414. PubMed ID: 27387546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast Cancer Risk and Mammographic Density Assessed with Semiautomated and Fully Automated Methods and BI-RADS.
    Jeffers AM; Sieh W; Lipson JA; Rothstein JH; McGuire V; Whittemore AS; Rubin DL
    Radiology; 2017 Feb; 282(2):348-355. PubMed ID: 27598536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer.
    Buist DSM; Abraham L; Lee CI; Lee JM; Lehman C; O'Meara ES; Stout NK; Henderson LM; Hill D; Wernli KJ; Haas JS; Tosteson ANA; Kerlikowske K; Onega T;
    JAMA Intern Med; 2018 Apr; 178(4):458-468. PubMed ID: 29435556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary evaluation of the publicly available Laboratory for Breast Radiodensity Assessment (LIBRA) software tool: comparison of fully automated area and volumetric density measures in a case-control study with digital mammography.
    Keller BM; Chen J; Daye D; Conant EF; Kontos D
    Breast Cancer Res; 2015 Aug; 17():117. PubMed ID: 26303303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor characteristics and family history in relation to mammographic density and breast cancer: The French E3N cohort.
    Maskarinec G; Dartois L; Delaloge S; Hopper J; Clavel-Chapelon F; Baglietto L
    Cancer Epidemiol; 2017 Aug; 49():156-160. PubMed ID: 28697417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammographic density, response to hormones, and breast cancer risk.
    Boyd NF; Melnichouk O; Martin LJ; Hislop G; Chiarelli AM; Yaffe MJ; Minkin S
    J Clin Oncol; 2011 Aug; 29(22):2985-92. PubMed ID: 21709206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.